Therapeutic traditions, patient socioeconomic characteristics and physicians’ early new drug prescribing–a multilevel analysis of rosuvastatin prescription in south Sweden

By Ohlsson Henrik   Chaix Basile   Merlo Juan  

European Journal of Clinical Pharmacology, Vol. 65, Iss. 2, 2009-02 ,pp. : 141-150

Springer Publishing Company

Access to resources Recommend Favorite

New information may help fight antibacterial resistance

By  

Inpharma, Vol. 1, Iss. 1378, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

The Dual Role of Company Prescribing Loyalty in New Drug Launches

By Glass Harold E.   Poli Laurence G.  

Journal of Pharmaceutical Marketing & Management, Vol. 16, Iss. 2, 2005-07 ,pp. : 47-62

Haworth Press

Access to resources Recommend Favorite

Inappropriate prescribing: intervention programme doesn't help

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 321, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

The Influence of Primary Care Prescribing Rates for New Drugs on Spontaneous Reporting of Adverse Drug Reactions

By Clark Richard C.  

Drug Safety, Vol. 30, Iss. 4, 2007-01 ,pp. : 357-366

Adis International

Access to resources Recommend Favorite